Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE5A | O76074 | 6/20 | 0.61 |
| ▸ | GUCY1A1 | Q02108 | 14/20 | 0.56 |
| ▸ | GUCY1B1 | Q02153 | 14/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13736593 | 0.86 | GUCY1A1 (0.53) | PDE5AGUCY1A1GUCY1B1 | |
| SCHEMBL15633165 | 0.85 | PDE5A (0.67) | PDE5AGUCY1A1GUCY1B1 | |
| SCHEMBL13732888 | 0.85 | PDE5A (0.72) | PDE5AGUCY1A1GUCY1B1 | |
| SCHEMBL13733670 | 0.84 | GUCY1A1 (0.61) | PDE5AGUCY1A1GUCY1B1 | |
| SCHEMBL327087 | 0.84 | GUCY1A1 (0.72) | PDE5AGUCY1A1GUCY1B1 | |
| SCHEMBL13733866 | 0.83 | PDE5A (0.89) | PDE5AGUCY1A1GUCY1B1 | |
| SCHEMBL9913994 | 0.81 | PDE5A (0.77) | PDE5A | |
| SCHEMBL14776955 | 0.80 | GUCY1A1 (0.69) | GUCY1A1GUCY1B1 | |
| SCHEMBL9913998 | 0.80 | PDE5A (0.77) | PDE5A | |
| SCHEMBL14776672 | 0.80 | GUCY1A1 (0.71) | GUCY1A1GUCY1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2699578-B1 | FLUOROALKYL-SUBSTITUTED PYRAZOLOPYRIDINES AND USE THEREOF | BAYER IP GMBH (DE) | 2016-04-20 | — | — | EP | disclosed |
| US-9090610-B2 | Fluoroalkyl-substituted pyrazolopyridines and use thereof | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-07-28 | — | — | US | disclosed |
| US-9090610-B2 | Fluoroalkyl-substituted pyrazolopyridines and use thereof | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-07-28 | — | — | US | disclosed |
| US-9090610-B2 | Fluoroalkyl-substituted pyrazolopyridines and use thereof | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2015-07-28 | — | — | US | disclosed |
| US-20140100229-A1 | FLUOROALKYL-SUBSTITUTED PYRAZOLOPYRIDINES AND USE THEREOF | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2014-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140100229-A1 | FLUOROALKYL-SUBSTITUTED PYRAZOLOPYRIDINES AND USE THEREOF | PON1, QDPR, FABP3 | PDE5A 304/4885GUCY1A1 2148/4885GUCY1B1 1166/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.